These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10924734)

  • 41. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
    Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
    Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
    Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL
    Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of octreotide on lipid metabolism in acromegaly.
    Cohen R; Chanson P; Bruckert E; Timsit J; Legrand A; Harris AG; Guillausseau PJ; Warnet A; Lubetzki J
    Horm Metab Res; 1992 Aug; 24(8):397-400. PubMed ID: 1526629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
    Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
    Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
    Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visceral leishmaniasis is associated with marked changes in serum lipid profile.
    Liberopoulos EN; Apostolou F; Gazi IF; Kostara C; Bairaktari ET; Tselepis AD; Elisaf M
    Eur J Clin Invest; 2014 Aug; 44(8):719-27. PubMed ID: 24920396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a).
    Svensson J; Jansson JO; Ottosson M; Johannsson G; Taskinen MR; Wiklund O; Bengtsson BA
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2028-33. PubMed ID: 10372705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B.
    Menys VC; Liu Y; Mackness MI; Caslake MJ; Kwok S; Durrington PN
    Clin Chim Acta; 2003 Aug; 334(1-2):95-106. PubMed ID: 12867279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.
    Sesmilo G; Fairfield WP; Katznelson L; Pulaski K; Freda PU; Bonert V; Dimaraki E; Stavrou S; Vance ML; Hayden D; Klibanski A
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1692-9. PubMed ID: 11932303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
    Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
    Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma fatty acids and lipoproteins in type 2 diabetic patients.
    Lapolla A; Sartore G; Della Rovere GR; Romanato G; Zambon S; Marin R; Manzato E; Fedele D
    Diabetes Metab Res Rev; 2006; 22(3):226-31. PubMed ID: 16308886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
    Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial.
    Alaupovic P; Fesmire JD; Hunnighake D; Domanski M; Forman S; Knatterud GL; Forrester J; Herd JA; Hoogwerf B; Campeau L; Gobel FL
    Atherosclerosis; 1999 Oct; 146(2):369-79. PubMed ID: 10532693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients.
    Fatti LM; Scacchi M; Lavezzi E; Pecori Giraldi F; De Martin M; Toja P; Michailidis G; Stramba-Badiale M; Cavagnini F
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):626-30. PubMed ID: 17054464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of ezetimibe on remnant-like particle cholesterol, lipoprotein (a), and oxidized low-density lipoprotein in patients with dyslipidemia.
    Nozue T; Michishita I; Mizuguchi I
    J Atheroscler Thromb; 2010 Feb; 17(1):37-44. PubMed ID: 20075599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of physical exercise on lipoprotein(a) and low-density lipoprotein modifications in type 1 and type 2 diabetic patients.
    Rigla M; Sánchez-Quesada JL; Ordóñez-Llanos J; Prat T; Caixàs A; Jorba O; Serra JR; de Leiva A; Pérez A
    Metabolism; 2000 May; 49(5):640-7. PubMed ID: 10831176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A PvuII polymorphism of the low density lipoprotein receptor gene is not associated with plasma concentrations of low density lipoproteins including LP(a).
    Klausen IC; Hansen PS; Gerdes LU; Rüdiger N; Gregersen N; Faergeman O
    Hum Genet; 1993 Mar; 91(2):193-5. PubMed ID: 8096495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of Helicobacter pylori in acromegalic patients during treatment with octreotide.
    Jones SL; Patchett S; Anderson JV; Farthing MJ; Besser GM; Wass JA
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):683-7. PubMed ID: 8736269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increase of serum lipoprotein (a) levels during growth hormone therapy in normal short children.
    Hershkovitz E; Belotserkovsky O; Limony Y; Leiberman E; Shany S; Phillip M
    Eur J Pediatr; 1998 Jan; 157(1):4-7. PubMed ID: 9461354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet.
    Faghihnia N; Tsimikas S; Miller ER; Witztum JL; Krauss RM
    J Lipid Res; 2010 Nov; 51(11):3324-30. PubMed ID: 20713651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.